Picture Demy-Colton BioFuture 2024 NYC 3 Biotech Breakthroughs 650x100px
Organisation › Details

Qiagen Marseille S.A.

Ipsogen, cancer profiler, develops and markets molecular diagnostic tests that help to map diseases and guide patients and oncologists' decisions along their therapeutic path. With more than 80 tests already used routinely worldwide for the diagnosis, prognosis and follow up of thousands of patients with leukemia, Ipsogen is now targeting breast cancer with the aim of providing currently inaccessible diagnostic information. Strengthened by its scientific, clinical and technological partnerships, and by its multidisciplinary team in France and the USA, Ipsogen intends to become a world leader in the molecular profiling of cancers, and to continue the development and promotion of best-in-class diagnostic references that have a significant impact on patients, medical professionals and society. The company is headquartered in Marseilles, France, and has a subsidiary in the US. *


Period Start 2013-01-01 renamed
  Group Qiagen (Group)
  Predecessor Ipsogen S.A.
Products Industry molecular diagnostics
  Industry 2 diagnostic test, cancer
Region Region Marseille
  Country France
  Street 163 avenue de Luminy
Luminy Biotech Entreprises, Case 923
  City 13288 Marseille Cedex 09
  Tel +33-4-9129-3090
    Address record changed: 2020-12-02
Basic data Employees B: 11 to 50 (2008-04-30)
    * Document for »About Section«: 
Record changed: 2024-02-12


Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x200px

More documents for Qiagen (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Demy-Colton BioFuture 2024 NYC Reimagine Healthcare 650x300px

» top